Denisa E. Ferastraoaru

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4f67ca10-b453-11ec-ac66-5b6382c5d80b.jpg

First Name

Denisa

Last Name

Ferastraoaru

NPI

1871866889

Faculty ID

14693

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black;">Dr. Denisa Ferastraoaru is Associate Professor of Medicine in Allergy and Immunology and attending physician at &nbsp;Einstein/ Montefiore and Jacobi Medical Centers. Dr. Ferastraoaru is board certified in both pediatric and adult Allergy /Immunology and Internal Medicine. She received her medical degree at Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. She completed an Internal Medicine residency at Jacobi Medical Center followed by her Allergy/Immunology fellowship at Montefiore Medical Center. Dr. Ferastraoaru treats both adults and children for a multitude of allergic disorders, including environmental and food allergies, asthma, urticaria, atopic dermatitis, contact dermatitis.&nbsp;</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black;">Dr. Ferastraoaru leads the IgE deficiency project where she made important research contributions to the association between absent IgE levels and higher risk of malignancy. In addition, Dr. Ferastraoaru is the Co-Director of the Chronic Sinusitis Clinic at Montefiore where she leads Local Allergic Rhinitis initiative, the only center in the tri-state area for Local Allergic Rhinitis diagnosis and treatment.&nbsp;</span></p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Ferastraoaru sees patients with a variety of allergic conditions: allergic rhinitis, acute and chronic sinusitis, allergic conjunctivitis, itching, skin rashes, urticaria, angioedema, atopic dermatitis, contact dermatitis, I.e. deficiency<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

56890

Biography

<p>Denisa Ferastraoaru, MD, is an attending physician and Associate Professor in Allergy-Immunology at Montefiore Einstein. Dr. Ferastraoaru is the Co-Director of the Montefiore Sinus and Allergy Center, where patients are seen by both an Allergist and Otolaryngologist to further diagnose and treat their sinonasal conditions. Dr. Ferastraoaru&rsquo;s clinical focus is on the care of patients with a variety of allergic conditions including allergic rhinitis, acute and chronic sinusitis, allergic conjunctivitis, itching, skin rashes, urticaria, angioedema, atopic dermatitis, contact dermatitis and immunoglobulin E (IgE) deficiency.</p>
<p>Educated in Romania, Dr. Ferastraoaru completed her medical education at University of Medicine and Pharmacy &ldquo;Carol Davila&rdquo; Bucharest. She then completed her Master in Bioengineering and Biotechnology – Medical and Clinical Engineering at Polytechnic University of Bucharest. She began her postgraduate training with a three-year allergy and clinical immunology residency at Nicolae Malaxa Hospital in Bucharest. She then came to the United States for further training at Einstein, completing a three-year residency in internal medicine followed by a two-year allergy-immunology fellowship.</p>
<p>Dr. Ferastraoaru’s research focus is in allergic rhinitis, sinusitis, local allergic rhinitis, skin rashes, and characterizing patients with IgE deficiency and their associated conditions. She is one of the very few providers in the USA who diagnoses and treats patients with local allergic rhinitis. Dr. Ferastraoaru is also among the very few researchers in the world who is studying IgE deficiency, being invited to lecture about this medical condition at several international meetings. She is mentoring students, residents and fellows in the field of Allergy-Immunology and she has shared her work through peer-reviewed journals, book chapters, abstracts and poster presentations. Dr. Ferastraoaru has been featured in different media healthcare platforms, where she provides education materials for patients with allergies.</p>
<p>Dr. Ferastraoaru is board certified in Internal Medicine and Allergy and Immunology. She is a member of the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology and the New York Allergy and Asthma Society. She has been selected among New York Top Doctors & Rising Stars by <em>New York Times Magazine</em> from 2018 through 2022.</p>

Visit Type ID

2498

Is Open Scheduling

On

Zocdoc Link

Sameen Farooq

https://assets.montefioreeinstein.org/profiles/images/sameen-farooq.jpg

First Name

Sameen

Last Name

Farooq

NPI

1912391822

Faculty ID

16635

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Dr. Farooq is board certified in Internal Medicine, Addiction Medicine, Palliative and Hospice Medicine and Obesity Medicine. He works as a direct care Internal Medicine hospitalist at Moses campus.</p>

EMR ID

76398

Is Open Scheduling

Off

Bianca N. Calderon

https://assets.montefioreeinstein.org/profiles/images/physphoto/Calderon_Bianca_MD_420x504.jpg

First Name

Bianca

Last Name

Calderon

NPI

1780003855

Faculty ID

15552

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Pediatric

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><strong>Education</strong></p>
<p>Medical School: Columbia University College of Physicians and Surgeons</p>
<p>Residency: Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center</p>
<p>&nbsp;</p>
<p><strong>Interests</strong></p>
<ul>
<li>Group well child care</li>
<li>Implicit bias and microaggressions in healthcare</li>
<li>Medical education</li>
</ul>
<p>&nbsp;</p>
<p>&nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Interested in community-based preventative medicine and population health. The emphasis is on helping patients achieve their health goals and optimizing their chronic diseases, and more importantly, discussing lifestyle modifications to prevent disease onset and progression, thereby improving and increasing life span.<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Calderon studies solutions to systems-based inequities in the field of pediatrics.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<ul>
<li>
<p><strong>Calderon-Brown, Bianca</strong>, and Randall Brown. <em>Minority Empowerment: How to Achieve Professional Success in America</em>. Floricanto Press, 2019.</p>
</li>
<li><strong>Calderon, Bianca</strong>. &ldquo;Pediatrician's Back to School Checklist.&rdquo; <em>Bronx Voice</em>, 30 Aug. 2018, bronxvoice.com/pediatrician/.</li>
</ul>

EMR ID

3122

Biography

<p>Bianca Calderon, MD, FAAP, is an attending physician and Assistant Professor of Pediatrics at Montefiore Einstein. Dr. Calderon is a school health physician with a special interest in adolescent reproductive healthcare.</p><p>In 2009, Dr. Calderon received her Bachelor of Arts from Harvard University. She went on to attend Columbia University College of Physicians and Surgeons, earning her medical degree in 2014. She then pursued postgraduate training at Morgan Stanley Children's Hospital of New York-Presbyterian/Columbia University Medical Center, completing her residency in pediatrics in 2017.</p><p>She is board certified in Pediatrics and is a Fellow of the American Academy of Pediatrics.</p>

Is Open Scheduling

Off

Nomeda Balcetis

https://assets.montefioreeinstein.org/profiles/images/physphoto/BALCETIS-Nomeda_420x504.jpg

First Name

Nomeda

Last Name

Balcetis

NPI

1508843756

Faculty ID

16542

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

83171

Is Open Scheduling

Off

Matthew J. Akiyama

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/a703c590-85e5-11ec-a5a4-39080ebc53e5.jpg

First Name

Matthew

Last Name

Akiyama

NPI

1316259419

Faculty ID

14789

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Akiyama is an Associate Professor of Medicine and Clinician-Investigator in the Divisions of General Internal Medicine and Infectious Diseases. In addition to providing care and treatment to people living with HIV, hepatitis C virus (HCV), and substance use disorders, Dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations with particular emphasis on the intersection of HCV in the criminal legal system and sub-Saharan Africa. Dr. Akiyama is the recipient of a K99/R00 award from the National Institute on Drug Abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir Award from the National Institute on Drug Abuse focused on HCV Transmission Networks Among People Who Inject Drugs.&nbsp;</p>
<p>Dr. Akiyama&nbsp;completed his Infectious Diseases Fellowship at New York University/Bellevue Hospital Center and a Master of Science in Medical Anthropology at University College London in London, England.&nbsp;</p>
<p><strong>Selected Awards</strong>&nbsp;<strong>&amp; Honors</strong></p>
<p>Recipient, Justice Community Opioid Innovation Network LEAP Investigator Scholarship (2020)</p>
<p>Member, New York State Governor's Hepatitis C Elimination Task Force (2018)</p>
<p>Albert Einstein College of Medicine KL2 Career Development Award (2017)</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Provide care and treatment to people living with and at risk for HIV, viral hepatitis, and substance use disorders.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Conduct research focusing on HIV and viral hepatitis.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<div class="cit">
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"><strong>Akiyama MJ</strong>, Spaulding AC, Nijhawan AE.&nbsp;Long-Acting Injectable Antiretrovirals in Incarcerated Populations - Challenges and Opportunities.&nbsp;</span></span><span style="font-family: Calibri, sans-serif; font-size: 16px;">N Engl J Med. 2</span><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">022 Nov 10;387(19):1728-1730.</span></span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Kronfli N, Cabezas J, Sheehan Y, Thurairajah PH, Lines R, Lloyd AR; International Network on Health and Hepatitis in Substance Users&ndash;Prisons Network.&nbsp;Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.&nbsp;Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">, Muller A, Huang O, Lizcano J, Nyakowa M, Riback L, Ross J, Bundi H, Kulabi ES, Mwangi AM, Musyoki H, Cherutich P, Kurth A.</span> Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative study. <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Glob Public Health. 2021 Mar 9:1-13.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Spaulding AC, Rich JD. Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons. N Engl J Med.&nbsp;2020 May 28;382(22):2075-2077.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Lipsey D,^&nbsp;Ganova-Raeva L, Punkova L, Agyemang L, Sue A, Ramachandran S, Khudyakov Y, Litwin AH. A Phylogenetic Analysis of HCV Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.&nbsp;J Infect Dis. 2020 Mar 9.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Cleland CM, Lizcano J, Cherutich P, Kurth A. Hepatitis C Prevalence, Estimated Incidence, Risk Behaviors, and Genotypic Distribution Among People Who Inject Drugs Accessing Harm Reduction Services in Kenya: A Retrospective Cohort Study. Lancet ID.&nbsp;2019 Nov;19(11):1255-1263.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Columbus D, MacDonald R, Jordan AO, Schwartz J, Litwin AH, Eckhardt B, Carmody E.&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pubmed/31395019"><span style="color: black;">Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial.</span></a>&nbsp;BMC Infect Dis. 2019 Aug 8;19(1):703.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Norton BL, Arnsten JH, Agyemang L, Heo M, Litwin AH.&nbsp;Intensive&nbsp;Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy.&nbsp;Annals of Internal Medicine.&nbsp;2019 Apr 9.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Spaulding AC, Graham CS,&nbsp;<strong>Akiyama MJ</strong>, Chhatwal J, Nijhawan AE, Ninburg MH, Rich JD, Strick LB, Taylor LE, Trooskin SB, Westergaard RP, Sabol WJ. HCV prevalence estimates among incarcerated persons.&nbsp;Hepatology. 2019 Apr 2.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Norton BL,&nbsp;<strong>Akiyama MJ</strong>, Zamor PJ, Litwin AH.&nbsp;Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice. Infect Dis Clin North Am. 2018 Jun;32(2):347-370.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Feffer R, Von Oehsen III WF, Litwin AH. Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System<strong>.&nbsp;</strong>AJPH. 2018 May;108(5):607-608.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Agyemang L, Arnsten, JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH.&nbsp;Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.&nbsp;BMC Infect Dis. 2018 Feb 9;18(1):74.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">MacDonald R,&nbsp;<strong>Akiyama MJ</strong>, Kopolow A, Rosner Z, McGahee W, Joseph R, Jaffer M, Venters H. Full Title: Feasibility of Treating Hepatitis C in a Transient Jail Population. Open Forum Infect Dis.&nbsp;2017 Jul 7;4(3):ofx142.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Kaba F, Rosner Z, Alper H, Kopolow A, Litwin A, Venters H, Macdonald R. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System: Epidemiologic Patterns and Priorities for Action. Public Health Reports.&nbsp;2017 Jan/Feb;132(1):41-47.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Kaba F, Rosner Z, Alper H, Holzman RS, MacDonald R. Hepatitis C Screening of the &ldquo;Birth Cohort&rdquo; (b. 1945-1965) and younger inmates of New York City Jails.&nbsp;AJPH.&nbsp;2016 Jul;106(7):1276-7.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Feller DJ,&nbsp;<strong>Akiyama MJ</strong>, Gordon P, Agins BD. Readmissions in HIV-infected Inpatients: A Large Cohort Analysis.&nbsp;JAIDS.&nbsp;2016 Apr 1;71(4):407-12.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">BardfieldJ, Agins B,&nbsp;<strong>Akiyama MJ</strong>, Mutandi G, Basenero A, Luphala P, Kaindjee-tjituka F, Natanael S, Hamunime N. A Quality Improvement Approach to Capacity Building in Low- and Middle-Income Countries: The case of HEALTHQUAL International. AIDS.&nbsp;2015 Jul;29 Suppl2:S179-86. &nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">Vo PK, Vutien P,&nbsp;<strong>Akiyama MJ</strong>, Vu VD, Ha NB, Piotrowski JI, Wantuck J, Roytman MM, Tsai N, Cheung R, Li J, Nguyen MH. Poor Sustained Virologic Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. Digestive Diseases and Sciences 2015 Apr;60(4):1045-51.</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: Calibri, sans-serif;"><strong>Akiyama MJ</strong>, Piotrowski JI, Roytman MM, Chan A, Hong LK, Huddleston L, Trujillo R, Tsai N. New Triple Therapy for Chronic Hepatitis C: Real Life Clinical Experience in a Community Setting. Hawaii Journal of&nbsp;Medicine and Public Health 2013 Sep;72(9 Suppl 4):6-13.&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>
</div>

EMR ID

78529

Is Open Scheduling

On